Xiaobo Yang

14.6k total citations · 2 hit papers
55 papers, 8.3k citations indexed

About

Xiaobo Yang is a scholar working on Molecular Biology, Critical Care and Intensive Care Medicine and Epidemiology. According to data from OpenAlex, Xiaobo Yang has authored 55 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Critical Care and Intensive Care Medicine and 10 papers in Epidemiology. Recurrent topics in Xiaobo Yang's work include COVID-19 Clinical Research Studies (7 papers), Intensive Care Unit Cognitive Disorders (7 papers) and Cardiac Arrest and Resuscitation (6 papers). Xiaobo Yang is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), Intensive Care Unit Cognitive Disorders (7 papers) and Cardiac Arrest and Resuscitation (6 papers). Xiaobo Yang collaborates with scholars based in China, Canada and Hong Kong. Xiaobo Yang's co-authors include You Shang, Jiqian Xu, Yu Yuan, Yaxin Wang, Yongran Wu, Huaqing Shu, Shangwen Pan, Shiying Yuan, Xiaojing Zou and Hong Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaobo Yang

50 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

2020 6.8k citations Xiaobo Yang, Yu Yuan et al. The Lancet Respiratory Medicine profile →
Thrombocytopenia and its association with mortality in patients with COVID‐19

2020 370 citations Xiaobo Yang, Yaxin Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaobo Yang China	20	5.2k	2.8k	1.3k	1.3k	1.0k	55	8.3k
Yu Yuan China	23	5.3k 1.0×	2.9k 1.0×	1.3k 1.0×	1.3k 1.0×	1.0k 1.0×	80	9.1k
Jiqian Xu China	19	5.2k 1.0×	2.8k 1.0×	1.3k 1.0×	1.3k 1.0×	953 0.9×	35	7.9k
Xiaojing Zou China	20	5.1k 1.0×	2.8k 1.0×	1.3k 1.0×	1.2k 0.9×	1.0k 1.0×	48	7.9k
Shangwen Pan China	15	4.9k 0.9×	2.7k 1.0×	1.3k 1.0×	1.1k 0.9×	884 0.9×	29	7.6k
Minghao Fang China	13	5.3k 1.0×	2.9k 1.0×	1.2k 0.9×	1.2k 0.9×	917 0.9×	29	7.8k
Zhui Yu China	12	4.9k 0.9×	2.8k 1.0×	1.2k 0.9×	1.1k 0.9×	894 0.9×	29	7.4k
Huaqing Shu China	15	4.9k 0.9×	2.7k 1.0×	1.2k 1.0×	1.1k 0.9×	862 0.9×	41	7.4k
Yaxin Wang China	26	5.2k 1.0×	2.8k 1.0×	1.5k 1.1×	1.4k 1.1×	1.0k 1.0×	54	8.7k
Shiying Yuan China	34	5.0k 1.0×	2.8k 1.0×	1.4k 1.1×	1.2k 0.9×	1.1k 1.1×	85	9.3k
Yongran Wu China	6	5.2k 1.0×	2.8k 1.0×	1.2k 0.9×	1.2k 1.0×	825 0.8×	14	7.2k

Countries citing papers authored by Xiaobo Yang

Since Specialization

Citations

This map shows the geographic impact of Xiaobo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Yang more than expected).

Fields of papers citing papers by Xiaobo Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Yang. The network helps show where Xiaobo Yang may publish in the future.

Co-authorship network of co-authors of Xiaobo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Yang. A scholar is included among the top collaborators of Xiaobo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Yang. Xiaobo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Xuehui, Xiaobo Yang, Yun Tang, et al.. (2024). Fospropofol disodium versus propofol for long-term sedation during invasive mechanical ventilation: A pilot randomized clinical trial. Journal of Clinical Anesthesia. 95. 111442–111442. 3 indexed citations

Yang, Xiaobo, et al.. (2024). Alpinia officinarum Hance extract relieved sepsis-induced myocardial ferroptosis and inflammation by inhibiting lncRNA MIAT/TRAF6/NF-κB axis. Allergologia et Immunopathologia. 52(5). 21–28. 1 indexed citations

Yang, Xiaobo, Xuehui Gao, Hongling Zhang, Jiqian Xu, & You Shang. (2024). Fungi identified via next-generation sequencing in bronchoalveolar lavage fluid among patients with COVID-19: a retrospective study. European journal of medical research. 29(1). 463–463. 1 indexed citations

Zou, Xiaojing, Hongling Zhang, Yongran Wu, et al.. (2024). Physiologic Comparison of Airway Pressure Release Ventilation and Low Tidal Volume Ventilation in ARDS. CHEST Journal. 167(2). 453–465. 2 indexed citations

Yang, Xiaobo, Yun Tang, Ruofei Du, et al.. (2023). Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial. Frontiers in Pharmacology. 14. 1139872–1139872. 3 indexed citations

Tang, Yun, Xiaobo Yang, Huaqing Shu, et al.. (2022). Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes. Minerva Anestesiologica. 88(11). 939–949. 18 indexed citations

Tang, Yun, Xiaobo Yang, Yuan Yu, et al.. (2022). Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study. Critical Care. 26(1). 279–279. 21 indexed citations

Tang, Yun, Xiaobo Yang, Huaqing Shu, et al.. (2021). Bioinformatic analysis identifies potential biomarkers and therapeutic targets of septic-shock-associated acute kidney injury. Hereditas. 158(1). 13–13. 31 indexed citations

Yang, Xiaobo, Yu Yuan, Jiqian Xu, et al.. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 8(5). 475–481. 6803 indexed citations breakdown →

10.

Yang, Xiaobo, Yiyi Yang, Shangwen Pan, et al.. (2019). Trichostatin A modulates the macrophage phenotype by enhancing autophagy to reduce inflammation during polymicrobial sepsis. International Immunopharmacology. 77. 105973–105973. 39 indexed citations

11.

Yang, Xiaobo, Josep Lupón, María Teresa Vidán, et al.. (2018). Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 7(23). e008251–e008251. 179 indexed citations

12.

Wang, Anqiang, Jianzhen Lin, Liangcai Wu, et al.. (2017). Association between proton pump inhibitors and hepatic encephalopathy. Medicine. 96(17). e6723–e6723. 23 indexed citations

13.

Jiang, Hong, et al.. (2017). PPARδ activation protects H9c2 cardiomyoblasts from LPS-induced apoptosis through the heme oxygenase-1-mediated suppression of NF-κB activation. Molecular Medicine Reports. 15(6). 3775–3780. 5 indexed citations

14.

Yang, Xiaobo & Bin Du. (2014). Does pulse pressure variation predict fluid responsiveness in critically ill patients? A systematic review and meta-analysis. Critical Care. 18(6). 650–650. 161 indexed citations

15.

Feng, Mei, et al.. (2012). Protective effect of saturated hydrogen saline against blue light-induced retinal damage in rats.. PubMed. 5(2). 151–7. 19 indexed citations

16.

He, Meian, Huan Guo, Xiaobo Yang, et al.. (2010). Genetic Variations in HSPA8 Gene Associated with Coronary Heart Disease Risk in a Chinese Population. PLoS ONE. 5(3). e9684–e9684. 24 indexed citations

17.

Wang, Feng, Maohui Feng, Ping Xu, et al.. (2008). The level of Hsp27 in lymphocytes is negatively associated with a higher risk of lung cancer. Cell Stress and Chaperones. 14(3). 245–251. 8 indexed citations

18.

Yang, Xiaobo, Jing Yuan, Jingjing Sun, et al.. (2007). Association between heat-shock protein 70 gene polymorphisms and DNA damage in peripheral blood lymphocytes among coke-oven workers. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 649(1-2). 221–229. 13 indexed citations

19.

Yang, Xiaobo, Jinping Zheng, Yun Bai, et al.. (2007). Using Lymphocyte and Plasma Hsp70 as Biomarkers for Assessing Coke Oven Exposure among Steel Workers. Environmental Health Perspectives. 115(11). 1573–1577. 45 indexed citations

20.

Chen, Yongwen, Yun Bai, Jing Yuan, et al.. (2006). Association of Polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 Genes with Levels of DNA Damage in Peripheral Blood Lymphocytes among Coke-Oven Workers. Cancer Epidemiology Biomarkers & Prevention. 15(9). 1703–1707. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact